Telix Total Assets vs Capital Lease Obligations Analysis
| TLX Stock | 15.76 0.16 1.03% |
Telix Pharmaceuticals financial indicator trend analysis is much more than just breaking down Telix Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Telix Pharmaceuticals is a good investment. Please check the relationship between Telix Pharmaceuticals Total Assets and its Capital Lease Obligations accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telix Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Total Assets vs Capital Lease Obligations
Total Assets vs Capital Lease Obligations Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Telix Pharmaceuticals Total Assets account and Capital Lease Obligations. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Telix Pharmaceuticals' Total Assets and Capital Lease Obligations is 0.92. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Capital Lease Obligations in the same time period over historical financial statements of Telix Pharmaceuticals Limited, assuming nothing else is changed. The correlation between historical values of Telix Pharmaceuticals' Total Assets and Capital Lease Obligations is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Telix Pharmaceuticals Limited are associated (or correlated) with its Capital Lease Obligations. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Lease Obligations has no effect on the direction of Total Assets i.e., Telix Pharmaceuticals' Total Assets and Capital Lease Obligations go up and down completely randomly.
Correlation Coefficient | 0.92 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Total Assets
Total assets refers to the total amount of Telix Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Telix Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Capital Lease Obligations
Telix Pharmaceuticals capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Telix Pharmaceuticals asset purchases. For example, Telix Pharmaceuticals can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Telix Pharmaceuticals control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.Most indicators from Telix Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Telix Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telix Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. Tax Provision is likely to rise to about (2 M) in 2024. Selling General Administrative is likely to drop to about 57.5 M in 2024
| 2021 | 2023 | 2024 (projected) | Depreciation And Amortization | 236.6K | 6.7M | 7.1M | Interest Income | 1K | 1.0M | 1.1M |
Telix Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Telix Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Telix Stock Analysis
When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.